Evrys Bio

Doylestown, United States

Evrys Bio is a pharmaceutical company for providing health care solutions to defend against the virus.

$34.3M raised

Jul 2021

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Evrys Bio raised?

Evrys Bio has raised $34.3M in total funding. The most recent round was Grant. The last funding was announced in July 2021.

Who are Evrys Bio's investors?

Evrys Bio's investors include Keiretsu Capital, Mid Atlantic Bio Angels, Defense Threat Reduction Agency (DTRA), ShangPharma Innovation.

Where is Evrys Bio headquartered?

Evrys Bio is headquartered in Doylestown, United States.

What does Evrys Bio do?

Evrys Bio is a pharmaceutical company for providing health care solutions to defend against the virus.

What stage is Evrys Bio at?

Evrys Bio is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 13, 2021.

MLA

"Evrys Bio — Funding & Investors." VCBacked, July 13, 2021, https://www.vcbacked.co/company/evrys-bio. Accessed July 2, 2026.

APA

VCBacked. (2021). Evrys Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/evrys-bio

Wikipedia (cite web)

{{cite web |title=Evrys Bio — Funding & Investors |url=https://www.vcbacked.co/company/evrys-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 13, 2021.